Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · IEX Real-Time Price · USD
9.52
-0.17 (-1.75%)
At close: Apr 17, 2024, 4:00 PM
9.35
-0.17 (-1.79%)
After-hours: Apr 17, 2024, 4:06 PM EDT
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $458.53 million as of April 17, 2024. Its market cap has decreased by -35.91% in one year.
Market Cap
458.53M
Enterprise Value
404.42M
1-Year Change
-35.91%
Ranking
Category
Stock Price
$9.52
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $458.53M, a decrease of -38.10%. That is a compound annual growth rate of -4.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 458.50M | -1.76% |
Apr 16, 2024 | 466.70M | -2.32% |
Apr 15, 2024 | 477.80M | 3.22% |
Apr 12, 2024 | 462.90M | 7.63% |
Apr 11, 2024 | 430.10M | -6.40% |
Apr 10, 2024 | 459.50M | 0.64% |
Apr 9, 2024 | 456.60M | 0.11% |
Apr 8, 2024 | 456.10M | 1.72% |
Apr 5, 2024 | 448.40M | 1.86% |
Apr 4, 2024 | 440.20M | -1.63% |
Apr 3, 2024 | 447.50M | 2.10% |
Apr 2, 2024 | 438.30M | 0.78% |
Apr 1, 2024 | 434.90M | 0.67% |
Mar 28, 2024 | 432.00M | -0.46% |
Mar 27, 2024 | 434.00M | 2.17% |
Mar 26, 2024 | 424.80M | 0.69% |
Mar 25, 2024 | 421.90M | -1.79% |
Mar 22, 2024 | 429.60M | -0.46% |
Mar 21, 2024 | 431.60M | -0.55% |
Mar 20, 2024 | 434.00M | 1.81% |
Mar 19, 2024 | 426.30M | 2.33% |
Mar 18, 2024 | 416.60M | 0.12% |
Mar 15, 2024 | 416.10M | 0.34% |
Mar 14, 2024 | 414.70M | -2.15% |
Mar 13, 2024 | 423.80M | 3.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
MultiPlan | 475.62M |
C4 Therapeutics | 471.29M |
PetIQ | 464.96M |
Third Harmonic Bio | 459.26M |
Editas Medicine | 458.98M |
Taysha Gene Therapies | 458.19M |
Travere Therapeutics | 455.83M |
LENZ Therapeutics | 451.94M |